SARISOL NO. 1 Drug Patent Profile
✉ Email this page to a colleague
When do Sarisol No. 1 patents expire, and when can generic versions of Sarisol No. 1 launch?
Sarisol No. 1 is a drug marketed by Halsey and is included in one NDA.
The generic ingredient in SARISOL NO. 1 is butabarbital sodium. There are nine drug master file entries for this compound. Additional details are available on the butabarbital sodium profile page.
Summary for SARISOL NO. 1
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 32 |
Patent Applications: | 296 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SARISOL NO. 1 at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for SARISOL NO. 1
US Patents and Regulatory Information for SARISOL NO. 1
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Halsey | SARISOL NO. 1 | butabarbital sodium | TABLET;ORAL | 084719-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |